
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses challenges associated with the integration of information technologies into pharmacy practice.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses challenges associated with the integration of information technologies into pharmacy practice.
This video was recorded at the 2015 NACDS Total Store Expo.






